{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:46:56Z","timestamp":1792018016032,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current barriers to achieving radical life extension include the inability to use syngeneic, youthful mesenchymal stem cells (MSCs) and the anti-regenerative effects of senescence-associated secretory phenotype (SASP) factors. We aim to overcome this by a combination approach in which senescent cell burden is reduced utilizing SenoVax\u2122 a dendritic cell based senolytic immunotherapy combined with syngeneic pluripotent stem cell derived MSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We induced hepatic injury and accelerated aging using two established murine models: carbon tetrachloride (CCl\u2084) mediated liver injury and doxorubicin induced systemic senescence. Animals were treated with control, SenoVax, pMSCs or the combination. Outcomes included biochemical and histologic indices of liver injury, circulating and tissue biomarkers of senescence (IL-11, YKL-40, IL-6, IL-23\u2009R) and regeneration (Klotho, FGF-2, neo-VEGF, GDF-11),<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both CCl\u2084 and doxorubicin induced a robust senescent phenotype characterized by increased pro-inflammatory and pro-fibrotic mediators and downregulation of regenerative biomarkers. Combined senolytic and pMSC therapy outperformed mono therapies and produced clear synergistic benefits, including significant biochemical improvement of liver failure parameters, reversal of accelerated aging features, and restoration of regenerative signaling pathways. Senolytic monotherapy yielded partial improvements, while pMSCs alone showed limited activity in the presence of a high senescent-cell burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings support a mechanistic model in which senescent cells and SASP factors directly suppress MSC-mediated tissue repair. Targeted senolytic immunotherapy enhances the efficacy of regenerative interventions and represents a promising combinatorial strategy for chronic disease management and potentially for modifying biological aging itself.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08221-y","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:25:10Z","timestamp":1780899910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synergistic senolytic\u2013regenerative therapy significantly extends healthspan and lifespan"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5611-374X","authenticated-orcid":false,"given":"Thomas E.","family":"Ichim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Markov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karenjan A.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladyslav","family":"Bykoriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Fortunati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Minev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman A.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Bajnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbie","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jurow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh Kumar","family":"Sankhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Furman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris N.","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"1","key":"8221_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13287-022-02770-x","volume":"13","author":"M Wu","year":"2022","unstructured":"Wu M, Chen L, Qi Y, Ci H, Mou S, Yang J, et al. Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin \u03b21\/ERK1\/2\/HIF-1\u03b1\/VEGF-A signaling pathway for off-the-shelf breast tissue engineering. STEM Cell Res Ther. 2022;13(1):99. https:\/\/doi.org\/10.1186\/s13287-022-02770-x.","journal-title":"STEM Cell Res Ther"},{"key":"8221_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbrep.2018.10.007","volume":"16","author":"YJ Kim","year":"2018","unstructured":"Kim YJ, Seo DH, Lee SH, Lee S-H, An G-H, Ahn H-J, et al. Conditioned media from human umbilical cord blood-derived mesenchymal stem cells stimulate rejuvenation function in human skin. Biochem Biophys Rep. 2018;16:96\u2013102. https:\/\/doi.org\/10.1016\/j.bbrep.2018.10.007.","journal-title":"Biochem Biophys Rep"},{"key":"8221_CR3","doi-asserted-by":"crossref","unstructured":"Yamaza T, et al. Mesenchymal stem cell-mediated ectopic hematopoiesis alleviates aging-related phenotype in immunocompromised mice. Vol. 113(11): Blood; 2009. p. 2595\u2013604.","DOI":"10.1182\/blood-2008-10-182246"},{"key":"8221_CR4","unstructured":"https:\/\/medcraveonline.com\/JSRT\/JSRT-10-00187.pdf."},{"key":"8221_CR5","doi-asserted-by":"publisher","unstructured":"Dorronsoro A, Santiago FE, Grassi D, Zhang T, Lai RC, McGowan SJ, et al. Mesenchymal stem cell-derived extracellular vesicles reduce senescence and extend health span in mouse models of aging. Aging Cell. 2021;20(4):e13337. https:\/\/doi.org\/10.1111\/acel.13337.","DOI":"10.1111\/acel.13337"},{"issue":"6","key":"8221_CR6","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1016\/j.ymthe.2025.02.003","volume":"33","author":"W Lu","year":"2025","unstructured":"Lu W, Allickson J. Mesenchymal stromal cell therapy: progress to date and future outlook. Mol Ther. 2025;33(6):2679\u201388. https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.003.","journal-title":"Mol Ther"},{"issue":"6","key":"8221_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sensebe L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell STEM Cell. 2018;22(6):824\u201333. https:\/\/doi.org\/10.1016\/j.stem.2018.05.004.","journal-title":"Cell STEM Cell"},{"issue":"1","key":"8221_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1186\/s12967-025-07099-6","volume":"23","author":"TE Ichim","year":"2025","unstructured":"Ichim TE, Ramos RA, Rath A, Castellano J, Azimi N, Veltmeyer JD, et al. Reversing coma by senolytics and stem cells: the future is now. J Transl Med. 2025;23(1):1060. https:\/\/doi.org\/10.1186\/s12967-025-07099-6.","journal-title":"J Transl Med"},{"issue":"23\u201324","key":"8221_CR9","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1101\/gad.343129.120","volume":"34","author":"J Birch","year":"2020","unstructured":"Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 2020;34(23\u201324):1565\u201376. https:\/\/doi.org\/10.1101\/gad.343129.120.","journal-title":"Genes Dev"},{"key":"8221_CR10","doi-asserted-by":"publisher","unstructured":"Zhang L, Pitcher LE, Yousefzadeh MJ, Niedernhofer LJ, Robbins PD, Zhu Y. Cellular senescence: a key therapeutic target in aging and diseases. J Clin Investigation. 2022;132(15). https:\/\/doi.org\/10.1172\/JCI158450.","DOI":"10.1172\/JCI158450"},{"issue":"12","key":"8221_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang B, Han J, Elisseeff JH, Demaria M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol. 2024;25(12):958\u201378. https:\/\/doi.org\/10.1038\/s41580-024-00727-x.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8221_CR12","doi-asserted-by":"publisher","unstructured":"Herbstein F, Sapochnik M, Attorresi A, Pollak C, Senin S, Gonilski-Pacin D, et al. The SASP factor IL -6 sustains cell-autonomous senescent cells via a cGAS - STING - NF\u03baB intracrine senescent noncanonical pathway. Aging Cell. 2024;23(10):e14258. https:\/\/doi.org\/10.1111\/acel.14258.","DOI":"10.1111\/acel.14258"},{"issue":"1","key":"8221_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12964-017-0172-3","volume":"15","author":"P Ortiz-Montero","year":"2017","unstructured":"Ortiz-Montero P, Londono-Vallejo A, Vernot JP. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence\/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun Signal. 2017;15(1):17. https:\/\/doi.org\/10.1186\/s12964-017-0172-3.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"8221_CR14","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.3390\/ijms25126732","volume":"25","author":"M Dema","year":"2024","unstructured":"Dema M, Eixarch H, Castillo M, Montalban X, Espejo C. IL-6 inhibition as a therapeutic target in aged experimental autoimmune encephalomyelitis. IJMS. 2024;25(12):6732. https:\/\/doi.org\/10.3390\/ijms25126732.","journal-title":"IJMS"},{"key":"8221_CR15","doi-asserted-by":"publisher","unstructured":"Dookun E, Walaszczyk A, Redgrave R, Palmowski P, Tual-Chalot S, Suwana A, et al. Clearance of senescent cells during cardiac ischemia\u2013reperfusion injury improves recovery. Aging Cell. 2020;19(10):e13249. https:\/\/doi.org\/10.1111\/acel.13249.","DOI":"10.1111\/acel.13249"},{"issue":"1","key":"8221_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s40001-025-02755-5","volume":"30","author":"J Zhou","year":"2025","unstructured":"Zhou J, An X, Xia X, Xiao W, Dou D, Li W, et al. Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis. Eur J Med Res. 2025;30(1):542. https:\/\/doi.org\/10.1186\/s40001-025-02755-5.","journal-title":"Eur J Med Res"},{"issue":"1","key":"8221_CR17","doi-asserted-by":"publisher","first-page":"19172","DOI":"10.1038\/s41598-023-46491-4","volume":"13","author":"M Vazquez-Del Mercado","year":"2023","unstructured":"Vazquez-Del Mercado M, P\u00e9rez-V\u00e1zquez F, M\u00e1rquez-Aguirre AL, Mart\u00ednez-Garc\u00eda E-A, Chavarria-Avila E, Ramos-Becerra CG, et al. YKL-40 serum levels are predicted by inflammatory state, age and diagnosis of idiopathic inflammatory myopathies. Sci Rep. 2023;13(1):19172. https:\/\/doi.org\/10.1038\/s41598-023-46491-4.","journal-title":"Sci Rep"},{"key":"8221_CR18","doi-asserted-by":"publisher","unstructured":"Ibarra-Sanchez A, Madera-Salcedo I, Esparza-Reyes D, Mendoza-Montiel P, Padilla J, Gonz\u00e1lez-Espinosa C. A prominent pro-inflammatory phenotype is observed in replication and stress-induced senescent mast cells. Aging Cell. 2025;24(10):e70186. https:\/\/doi.org\/10.1111\/acel.70186.","DOI":"10.1111\/acel.70186"},{"issue":"1","key":"8221_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13287-020-1550-0","volume":"11","author":"M Shao","year":"2020","unstructured":"Shao M, Xu Q, Wu Z, Chen Y, Shu Y, Cao X, et al. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. STEM Cell Res Ther. 2020;11(1):37. https:\/\/doi.org\/10.1186\/s13287-020-1550-0.","journal-title":"STEM Cell Res Ther"},{"issue":"1","key":"8221_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12915-021-01058-5","volume":"19","author":"S Beji","year":"2021","unstructured":"Beji S, D\u2019Agostino M, Gambini E, Sileno S, Scopece A, Vinci MC, et al. Doxorubicin induces an alarmin-like TLR4-dependent autocrine\/paracrine action of nucleophosmin in human cardiac mesenchymal progenitor cells. BMC Biol. 2021;19(1):124. https:\/\/doi.org\/10.1186\/s12915-021-01058-5.","journal-title":"BMC Biol"},{"issue":"6","key":"8221_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10522-023-10054-x","volume":"24","author":"P Borsky","year":"2023","unstructured":"Borsky P, Holmannova D, Andrys C, Kremlacek J, Fiala Z, Parova H, et al. Evaluation of potential aging biomarkers in healthy individuals: telomerase, AGEs, GDF11\/15, sirtuin 1, NAD+, NLRP3, DNA\/RNA damage, and klotho. Biogerontology. 2023;24(6):937\u201355. https:\/\/doi.org\/10.1007\/s10522-023-10054-x.","journal-title":"Biogerontology"},{"issue":"18","key":"8221_CR22","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1111\/febs.17164","volume":"291","author":"W Xia","year":"2024","unstructured":"Xia W, Chen H, Yang H, Zhu L, Xie C, Hou M. Depletion of SASP senescent cardiomyocytes with senolytic drugs confers therapeutic effects in doxorubicin-related cardiotoxicity. The FEBS J. 2024;291(18):4029\u201342. https:\/\/doi.org\/10.1111\/febs.17164.","journal-title":"The FEBS J"},{"key":"8221_CR23","doi-asserted-by":"publisher","first-page":"112007","DOI":"10.1016\/j.mad.2024.112007","volume":"223","author":"M Scalise","year":"2025","unstructured":"Scalise M, Cianflone E, Quercia C, Pagano L, Chiefalo A, Stincelli A, et al. Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids. Mechanisms Ageing Devel. 2025;223:112007. https:\/\/doi.org\/10.1016\/j.mad.2024.112007.","journal-title":"Mechanisms Ageing Devel"},{"issue":"23","key":"8221_CR24","doi-asserted-by":"publisher","first-page":"25256","DOI":"10.18632\/aging.203743","volume":"13","author":"W Xia","year":"2021","unstructured":"Xia W, Chang B, Li L, Hu T, Ye J, Chen H, et al. MicroRNA therapy confers anti-senescent effects on doxorubicin-related cardiotoxicity by intracellular and paracrine signaling. Aging (Albany NY). Aging. 2021;13(23):25256\u201370. https:\/\/doi.org\/10.18632\/aging.203743.","journal-title":"Aging"},{"issue":"1","key":"8221_CR25","doi-asserted-by":"publisher","first-page":"26544","DOI":"10.1038\/s41598-024-78183-y","volume":"14","author":"K He","year":"2024","unstructured":"He K, Wei D, Liu Q, Liu X, Zhou D, Chen S, et al. Identification of stable housekeeping genes in mouse liver for studying carbon tetrachloride-induced injury and cellular senescence. Sci Rep. 2024;14(1):26544. https:\/\/doi.org\/10.1038\/s41598-024-78183-y.","journal-title":"Sci Rep"},{"key":"8221_CR26","doi-asserted-by":"publisher","first-page":"622950","DOI":"10.3389\/fendo.2020.622950","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Lu L, Xie Y, Chen X, Tian L, Liang Y, et al. Interleukin-6 knockout inhibits senescence of Bone mesenchymal stem cells in high-fat diet-induced Bone loss. Front. Endocrinol. 2021;11:622950. https:\/\/doi.org\/10.3389\/fendo.2020.622950.","journal-title":"Front. Endocrinol"},{"key":"8221_CR27","doi-asserted-by":"publisher","unstructured":"Perez JA, Parcero Valdes JJ, Corral Moreno R, Gomez Cuevas LI, Lopez JJ, Ichim T, et al. Intravenous administration of umbilical cord-derived mesenchymal stem cells (UC-MSC) for acute respiratory distress syndrome due to COVID-19 infection. Cureus. 2023;15(8):e44110. https:\/\/doi.org\/10.7759\/cureus.44110.","DOI":"10.7759\/cureus.44110"},{"issue":"1","key":"8221_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/jtim-2025-0005","volume":"13","author":"TE Fu","year":"2025","unstructured":"Fu TE, Zhou Z. Senescent cells as a target for anti-aging interventions: from senolytics to immune therapies. J Transl Int Med. 2025;13(1):33\u201347. https:\/\/doi.org\/10.1515\/jtim-2025-0005.","journal-title":"J Transl Int Med"},{"issue":"1","key":"8221_CR29","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1186\/s12967-025-07393-3","volume":"23","author":"TE Ichim","year":"2025","unstructured":"Ichim TE, Lopes G, Reznik R, Bykoriz V, Fortunati CA, Pascual KA, et al. Reduction of solid tumors by senescent cell immunization. J Transl Med. 2025;23(1):1365. https:\/\/doi.org\/10.1186\/s12967-025-07393-3.","journal-title":"J Transl Med"},{"key":"8221_CR30","doi-asserted-by":"publisher","unstructured":"Gutierrez-Reyes G, Garcia de Leon MDC, Varela-Fascinetto G, Valencia P, P\u00e9rez Tamayo R, Rosado CG, et al. Cellular senescence in livers from children with end stage liver disease. PLoS One. 2010;5(4):e10231. https:\/\/doi.org\/10.1371\/journal.pone.0010231.","DOI":"10.1371\/journal.pone.0010231"},{"issue":"7","key":"8221_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1136\/gut.2003.027516","volume":"53","author":"R Sato","year":"2004","unstructured":"Sato R, Maesawa C, Fujisawa K, Wada K, Oikawa K, Takikawa Y, et al. Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis. Gut. 2004;53(7):1001\u201309. https:\/\/doi.org\/10.1136\/gut.2003.027516.","journal-title":"Gut"},{"issue":"7814","key":"8221_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor C, Feucht J, Leibold J, Ho Y-J, Zhu C, Alonso-Curbelo D, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 2020;583(7814):127\u201332. https:\/\/doi.org\/10.1038\/s41586-020-2403-9.","journal-title":"Nature"},{"issue":"8","key":"8221_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2460\/ajvr.25.03.0074","volume":"86","author":"A Fotouh","year":"2025","unstructured":"Fotouh A, Elbarbary NK, Momenah MA, Khormi MA, Mohamed WH, Sherkawy HS, et al. Hepatoprotective effects of mesenchymal stem cells in carbon tetrachloride\u2013induced liver toxicity in rats: restoration of liver parameters and histopathological evaluation. ajvr. 2025;86(8):1\u201310. https:\/\/doi.org\/10.2460\/ajvr.25.03.0074.","journal-title":"ajvr"},{"key":"8221_CR34","doi-asserted-by":"publisher","first-page":"1510337","DOI":"10.3389\/fphar.2025.1510337","volume":"16","author":"A Garg","year":"2025","unstructured":"Garg A, Saroj J, Tiwari S, Das U, Shukla N, Ghosh JK, et al. Exploring the potential anti-senescence effects of soybean-derived peptide soymetide in mice hippocampal neurons via the Wnt\/\u03b2-catenin pathway. Front Pharmacol. 2025;16:1510337. https:\/\/doi.org\/10.3389\/fphar.2025.1510337.","journal-title":"Front Pharmacol"},{"key":"8221_CR35","doi-asserted-by":"publisher","unstructured":"Wang J, Liu W, Huang Y, Wang G, Guo X, Shi D, et al. A Senomorphlytic three-Drug combination discovered in Salsola collina for delaying aging phenotypes and extending Healthspan. Adv Sci. 2024;11(36):e2401862. https:\/\/doi.org\/10.1002\/advs.202401862.","DOI":"10.1002\/advs.202401862"},{"issue":"8","key":"8221_CR36","first-page":"1142","volume":"18","author":"XH Nie","year":"2014","unstructured":"Nie XH, Han T, Ha F-U, Liang N, Wang S-H, Zhu Z-Y, et al. Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine. Eur Rev Med Pharmacol Sci. 2014;18(8):1142\u201350.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8221_CR37","doi-asserted-by":"publisher","unstructured":"Liu Y, Lin J, Chen Y, Li Z, Zhou J, Lu X, et al. Omega\u20113 polyunsaturated fatty acids inhibit IL\u201111\/STAT3 signaling in hepatocytes during acetaminophen hepatotoxicity. Int J Mol Med. 2021;48(4). https:\/\/doi.org\/10.3892\/ijmm.2021.5023.","DOI":"10.3892\/ijmm.2021.5023"},{"issue":"2\u20133","key":"8221_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.trim.2013.12.003","volume":"30","author":"V Tiriveedhi","year":"2014","unstructured":"Tiriveedhi V, Upadhya GA, Busch RA, Gunter KL, Dines JN, Knolhoff BL, et al. Protective role of bortezomib in steatotic liver ischemia\/reperfusion injury through abrogation of MMP activation and YKL-40 expression. Transpl Immunol. 2014;30(2\u20133):93\u201398. https:\/\/doi.org\/10.1016\/j.trim.2013.12.003.","journal-title":"Transpl Immunol"},{"issue":"10","key":"8221_CR39","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s40618-025-02649-7","volume":"48","author":"F Zhang","year":"2025","unstructured":"Zhang F, Han Y, Mao Y, Zheng L, Li W. Association of serum chitinase-3-like protein 1 with sarcopenia in patients with type 2 diabetes mellitus. J Endocrinol Invest. 2025;48(10):2445\u201357. https:\/\/doi.org\/10.1007\/s40618-025-02649-7.","journal-title":"J Endocrinol Invest"},{"issue":"14","key":"8221_CR40","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1167\/iovs.19-27493","volume":"60","author":"N Xu","year":"2019","unstructured":"Xu N, Bo Q, Shao R, Liang J, Zhai Y, Yang S, et al. Chitinase-3-like-1 promotes M2 macrophage differentiation and induces choroidal neovascularization in neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2019;60(14):4596\u2013605. https:\/\/doi.org\/10.1167\/iovs.19-27493.","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"issue":"4","key":"8221_CR41","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.ijcard.2012.04.006","volume":"167","author":"SCW Marott","year":"2013","unstructured":"Marott SCW, Benn M, Johansen JS, Jensen GB, Tybj\u00e6rg-Hansen A, Nordestgaard BG. YKL-40 levels and atrial fibrillation in the general population. Int J Cardiol. 2013;167(4):1354\u201359. https:\/\/doi.org\/10.1016\/j.ijcard.2012.04.006.","journal-title":"Int J Cardiol"},{"key":"8221_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7554\/eLife.68571","volume":"10","author":"Z Shan","year":"2021","unstructured":"Shan Z, Li L, Atkins CL, Wang M, Wen Y, Jeong J, et al. Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment. Elife. 2021;10:10. https:\/\/doi.org\/10.7554\/eLife.68571.","journal-title":"Elife"},{"key":"8221_CR43","doi-asserted-by":"publisher","unstructured":"Bird TG, M\u00fcller M, Boulter L, Vincent DF, Ridgway RA, Lopez-Guadamillas E, et al. TGF\u03b2 inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence. Sci Transl Med. 2018;10(454). https:\/\/doi.org\/10.1126\/scitranslmed.aan1230.","DOI":"10.1126\/scitranslmed.aan1230"},{"key":"8221_CR44","doi-asserted-by":"publisher","first-page":"111588","DOI":"10.1016\/j.exger.2021.111588","volume":"155","author":"A Kowald","year":"2021","unstructured":"Kowald A, Kirkwood TBL. Senolytics and the compression of late-life mortality. Exp Gerontology. 2021;155:111588. https:\/\/doi.org\/10.1016\/j.exger.2021.111588.","journal-title":"Exp Gerontology"},{"issue":"7","key":"8221_CR45","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.3390\/ijms27073175","volume":"27","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Yu Y, Yang S, Lu Y, Pan X. The efficacy of mesenchymal stem cell therapy in large animal models of acute liver failure: a meta-analysis. IJMS. 2026;27(7):3175. https:\/\/doi.org\/10.3390\/ijms27073175.","journal-title":"IJMS"},{"issue":"3","key":"8221_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10522-025-10240-z","volume":"26","author":"E Rudnitsky","year":"2025","unstructured":"Rudnitsky E, Braiman A, Wolfson M, Muradian KK, Gorbunova V, Turgeman G, et al. Mesenchymal stem cells and their derivatives as potential longevity-promoting tools. Biogerontology. 2025;26(3):96. https:\/\/doi.org\/10.1007\/s10522-025-10240-z.","journal-title":"Biogerontology"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08221-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08221-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08221-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:47:15Z","timestamp":1780908435000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08221-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8221"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08221-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have reviewed and approved the submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This work was supported by Immorta Bio Inc, a scientific longevity company focused on treating disease of aging and aging as disease with over 27 patents pending. TEI, VB, AR are management and shareholders of Immorta Bio Inc. GL is a member of the Scientific Advisory Board of Immorta Bio Inc.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"745"}}